ライフサイエンスコーパス: visual acuity

1 eading acuity (higher number indicates lower visual acuity).

2 lity change expected from a 1-line change in visual acuity).

3 OFF and ON-OFF light responses and improved visual acuity.

4 logy was significantly associated with lower visual acuity.

5 ce or progression of DME or DR and change in visual acuity.

6 ss [SFCT], phakic status, and best-corrected visual acuity.

7 nt Diabetic Retinopathy Study best-corrected visual acuity.

8 proper transmission of light to the lens and visual acuity.

9 d adjusting for age, sex, race, and starting visual acuity.

10 anges in eyes with DR that are correlated to visual acuity.

11 raphic information on visual function beyond visual acuity.

12 ell disease, even if asymptomatic with 20/20 visual acuity.

13 carring and vascularization and worse logMAR visual acuity.

14 se suffering from metamorphopsia and reduced visual acuity.

15 treatment regimens, culture data, and final visual acuities.

16 ION events (standardized mean differences of visual acuity 0.008, P = 0.890; and visual field loss, -

17 years) visual loss (mean [SD] best-corrected visual acuity, +0.95 [0.34] logMAR [20/180 Snellen]), ch

18 points (95% CI, -15.0 to 0.9) of those with visual acuity 20/40 or better initially, a clinically me

19 s (average, by 3 years), better preoperative visual acuity (22% vs. 32% with 0.4 logarithm of the min

20 Best-corrected visual acuity after Descemet's stripping endothelial ker

21 There was no difference in visual acuity, although more tIOL patients gained >/=1 l

22 y at 3 months after controlling for baseline visual acuity, although this finding was not statistical

23 Visual acuity, amblyopia, school performance, functionin

24 To report differences in visual acuities among patients with Coats' disease who s

25 ocular disorder that may result in a loss of visual acuity and accounts for approximately 10% of chil

26 abo, Puerto Rico, who presented with reduced visual acuity and bilateral diffuse, subretinal, conflue

27 ermore, they suggest that the development of visual acuity and binocularity in mice involves differen

28 costeroid therapy, most patients show stable visual acuity and CCT, although ECD decreases.

29 Primary outcomes were change in visual acuity and change in central retinal thickness on

30 Evolution of visual acuity and clinical stage of BVMD correlated to O

31 photopic conditions in binocular uncorrected visual acuity and contrast sensitivity suggest low pupil

32 pe mice exhibited functional deficiencies in visual acuity and contrast sensitivity, whereas diabetic

33 ative and postoperative uncorrected distance visual acuity and corrected distance visual acuity, the

34 ositive correlation was found between logMAR visual acuity and FAZ area in both the superficial (rho

35 The data from this study suggest that visual acuity and foveal structure in patients with RP a

36 ly S-cones and rods, suffer severely reduced visual acuity and impaired color vision.

37 Relationship between visual acuity and MA, and the baseline risk factors for

38 Cases with normal visual acuity and mild glaucoma had significantly higher

39 patients with CPR-type diplopia have better visual acuity and more metamorphopsia than those without

40 ith subretinal/sub-RPE hemorrhage and poorer visual acuity and of SNPs at the CFH locus with drusen a

41 c and/or environmental factors, compromising visual acuity and often resulting in blindness.

42 seline ophthalmic characteristics, including visual acuity and retinal thickness, and medical history

43 Visual acuity and RNFL thickness also showed greater dim

44 611PV and FIL618 provided better uncorrected visual acuity and spectacles independence for intermedia

45 Worse initial visual acuity and visual fields were associated with low

46 Visual acuity and visual thresholds; total nuclear layer

47 To evaluate how authors currently report visual acuity and whether they provide Snellen equivalen

48 t-reported outcomes (symptoms, cosmesis) and visual acuity, and evaluate effects of surgical variatio

49 ort the outcomes of survival, local control, visual acuity, and eye retention in patients treated wit

50 eepithelialization, best spectacle-corrected visual acuity, and infiltrate or scar size at 3 months.

51 ocular history, family history of glaucoma, visual acuity, and intraocular pressure measurements usi

52 e visual acuity (CDVA), uncorrected distance visual acuity, and minimum corneal thickness were assess

53 ncluded patient demographics, best-corrected visual acuity, and OCT features of vitreomacular adhesio

54 They presented with a 20/20 distance visual acuity, and Parinaud 1,5 near visual acuity in bo

55 lood pressure, and lipid levels), presenting visual acuity, and socioeconomic indicators.

56 tions), nonpersistent loss of best-corrected visual acuity, and transient hypotony (requiring no surg

57 e, ranging from night blindness to decreased visual acuity, and were diagnosed between the ages of 1

58 Detailed history, visual acuity, anterior segment and posterior segment ex

59 e was not a correlation between preoperative visual acuity as a predictor of final postoperative visu

60 sed as input data and corresponding recorded visual acuity as the target data to train, validate, and

61 logMAR (improved) (Snellen equivalent 20/40) visual acuity at 3 months after controlling for baseline

62 , 14283 cohort members with complete data on visual acuity at age 15 or 16 years, measured in 1961, 1

63 anretinal photocoagulation (PRP), as well as visual acuity at baseline and at 1 year.

64 findings and compare choroidal thickness and visual acuity at each time point.

65 Best-corrected visual acuity at fluid resolution was not statistically

66 e associated with increased risk of MVL; and visual acuity at referral, local therapy, macular scarri

67 On multivariate analysis, visual acuity at referral, retinal pigment epithelial at

68 cin after surgery; 5 of these 7 eyes had NLP visual acuity at the most recent examination.

69 d (UCDVA) and best-corrected distance logMAR visual acuity (BCDVA) at 12 months.

70 macular diseases and best-corrected distance visual acuity (BCDVAbetter-eye) of 20/50 to 20/200.

71 5 years, had wet AMD, and had best-corrected visual acuity (BCVA) 10/200 to 20/80 in the study eye an

72 Best-corrected visual acuity (BCVA) 6 months after surgery.

73 gate the relationship between best-corrected visual acuity (BCVA) and central retinal thickness (CRT)

74 rative-effectiveness study of best-corrected visual acuity (BCVA) and refractive error (RE) after imm

75 Best corrected visual acuity (BCVA) and stereoacuity (Stereo Randot gra

76 The primary outcome was best-corrected visual acuity (BCVA) at 6 months follow-up.

77 a 1-sided alpha level 0.1) in best-corrected visual acuity (BCVA) change from baseline of brolucizuma

78 y and the patients (%) with a best-corrected visual acuity (BCVA) improvement of >/=15 letters from p

79 Mean best-corrected visual acuity (BCVA) letter score change, proportion of

80 The mean preoperative best-corrected visual acuity (BCVA) was 1.39+/-0.64 logarithm of the mi

81 resolution (logMAR) (Snellen) best-corrected visual acuity (BCVA) was 1.81+/-0.56 (20/1290).

82 Median best-corrected visual acuity (BCVA) was 20/30 at presentation (IQR, 0.0

83 median preoperative and final best-corrected visual acuity (BCVA) was assessed and the outcomes are r

84 Best-corrected visual acuity (BCVA) was compared between late AMD subty

85 Mean change from baseline best-corrected visual acuity (BCVA) was determined at week 12, after wh

86 Best-corrected visual acuity (BCVA) was measured 30 to 90 days preopera

87 oherence tomography (SD-OCT), best-corrected visual acuity (BCVA), and microperimetry.

88 Best corrected visual acuity (BCVA), central retinal thickness (CRT) an

89 bA1c), body mass index (BMI), best-corrected visual acuity (BCVA), central subfield thickness (CST),

90 e measures were postoperative best-corrected visual acuity (BCVA), endothelial cell density (ECD), an

91 classic stages and underwent best-corrected visual acuity (BCVA), fundus autofluorescence and spectr

92 opathy, optic neuropathy, and best-corrected visual acuity (BCVA).

93 Ocular surface stability, best-corrected visual acuity (BCVA).

94 ations, device retention, and best-corrected visual acuity (BCVA).

95 mum) and the visual outcome (best corrected visual acuity (BCVA); logMAR), as follows: before treatm

96 We recorded Snellen visual acuity before and after intervention, as well as

97 uiring enhancement, the uncorrected distance visual acuity before enhancement ranged from 20/80 to 20

98 Visual acuities better than 0.2 LogMAR were maintained b

99 tcome measures were best spectacle-corrected visual acuity (BSCVA) with astigmatism (cylinder) and sp

100 We assessed 3-month best spectacle-corrected visual acuity (BSCVA), 3-month infiltrate/scar size, cor

101 al thickness (CCT), best spectacle-corrected visual acuity (BSCVA), and endothelial cell density (ECD

102 of graft rejection, best spectacle-corrected visual acuity (BSCVA), central corneal thickness (CCT),

103 parameters included best spectacle corrected visual acuity (BSCVA), central corneal thickness (CCT),

104 Best spectacle-corrected visual acuity (BSCVA), manifest refraction, and endothel

105 issection obtained; best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), and

106 ith sickle cell disease exhibiting preserved visual acuity but showing temporal macular retinal atrop

107 eeing through two eyes is thought to improve visual acuity by enhancing sensitivity to fine edges.

108 ogMAR +/- 0.06; monocular distance corrected visual acuity (CDVA), 0.02 logMAR +/- 0.06; binocular un

109 m baseline to 6 months in corrected distance visual acuity (CDVA), uncorrected distance visual acuity

110 wed for complications and corrected distance visual acuity (CDVA).

111 her outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of r

112 Other outcomes included visual acuity, central subfield retinal thickness, and n

113 Best-corrected visual acuity changed by -0.2 letters in the YAG laser g

114 visual acuity in uveitic eyes (5 letters = 1 visual acuity chart line; potential range of change in l

115 Visual acuity, clinical course, and multimodal imaging s

116 Visual acuity correlated with foveal avascular zone area

117 based vision screenings (presenting distance visual acuity, cover test, eye assessment history, colou

118 tions included cover testing, best corrected visual acuity, cycloplegic objective refraction, slit la

119 d intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic me

120 hors to provide Snellen equivalents whenever visual acuity data are reported in a non-Snellen format

121 visual acuity (UCVA) and distance-corrected visual acuity (DCVA) in 4 m, 80 cm, 60 cm, and 40 cm sli

122 Age at onset, visual acuity survival time, visual acuity decline rate, and electroretinography and

123 n the majority of patients but despite this, visual acuities did not deteriorate significantly over t

124 Visual acuity did not decrease significantly after the t

125 Because best-corrected visual acuity does not correspond directly to GA lesion

126 The visual acuity during last follow-up was 20/231 (range, l

127 plorations: best-corrected distance and near visual acuity evaluation; dilated fundus examination; OC

128 Improvements in visual acuity for the three working distances were stati

129 helps patients maintain better than expected visual acuity for years.

130 Change in mean visual acuity from baseline (implant, 61.7; systemic the

131 the change in mean and median best-corrected visual acuity from baseline at years 1 and 2.

132 velop a neural network for the estimation of visual acuity from optical coherence tomography (OCT) im

133 IDH3A variants, age at diagnosis, visual acuity, fundus appearance, visual field, and full

134 jective, demonstrating a mean best-corrected visual acuity gain of 8.3 letters (mean 68.8 +/- 11) at

135 Best-corrected visual acuity gains achieved during VISTA DME were maint

136 Visual acuity had improved in early tears before the tea

137 ks, the chorioretinal lesions had healed and visual acuity had improved to 20/25 OD and 20/20 OS.

138 s after the onset of symptoms, the patient's visual acuity had improved to 20/60 OD and 20/25 OS, wit

139 the eyelid and globes, as well as decreased visual acuity have all been observed.

140 The relevance of these findings relative to visual acuity, however, remains largely unknown at this

141 with reappearance of the ellipsoid line and visual acuity improved from 20/100 before surgery to 20/

142 Visual acuity improved in almost all eyes that underwent

143 Uncorrected distance visual acuity improved substantially in all eyes (from m

144 Visual acuity improved when IZ was restored.

145 ther class of anesthesia conferred a greater visual acuity improvement (p=0.06).

146 istance visual acuity, and Parinaud 1,5 near visual acuity in both eyes.

147 sing prevalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in

148 ization were important determinants of final visual acuity in eyes with the cuticular drusen phenotyp

149 Visual acuity in LE was no light perception.

150 s curve; monocular and binocular uncorrected visual acuity in photopic and mesopic conditions, for fa

151 Mean binocular uncorrected visual acuity in photopic conditions was 0.03 LogMAR for

152 y is a safe and effective means of improving visual acuity in RP patients and that it does not seem t

153 Visual acuity in the best eye decreases to below 0.5 in

154 c groups, adjusting for age, sex, presenting visual acuity in the better-seeing eye, educational leve

155 s did not have lenses fitted because of good visual acuity in the other eye or a contraindication for

156 e was change from baseline in best-corrected visual acuity in uveitic eyes (5 letters = 1 visual acui

157 infiltrates, which did not affect the final visual acuity, in the standard CL group.

158 reoperative and postoperative best-corrected visual acuity, incidence of macular edema, posterior cap

159 udies were included in the meta- analysis of visual acuity, including 9 retrospective reports and one

160 Visual acuity increased statistically significantly from

161 Best-corrected visual acuity, Indian Vision Function Questionnaire (IND

162 travitreal injections of a specific drug and visual acuity interval.

163 ls fail to provide a Snellen equivalent when visual acuity is not in a Snellen format.

164 Visual acuity, Kaplan-Meier estimates of survival, local

165 line, older age, hypercholesterolemia, worse visual acuity, larger choroidal neovascularization (CNV)

166 Visual acuity, length of ETU stay, and structural compli

167 or children with vision impairment (recorded visual acuity less than 6/18 for distance in the better

168 reased in those cases with better presenting visual acuities, lesser foveal thicknesses, and no assoc

169 relationship between NEI VFQ-25 scores with visual acuity letter score (VALS) and central retinal th

170 Best-corrected visual acuity letter score gain of 15 letters or more wa

171 At baseline, mean visual acuity letter score was 50 (20/100) (range, 19-73

172 had better visual outcomes (12-month median visual acuity, logarithm of the minimum angle of resolut

173 Median BCVA (best-corrected visual acuity, logMAR) was 0.1 in the MFS group versus 0

174 respecified criteria of at least a 10-letter visual acuity loss at 2 consecutive visits or at least a

175 2 consecutive visits or at least a 15-letter visual acuity loss from the best previous measurement at

176 est that the development of binocularity and visual acuity may engage distinct circuits in the mouse

177 t, all except 1 maintained or improved their visual acuity (mean [SD], +3.8 [9.6] letters).

178 with CPR-type diplopia had better worse-eye visual acuity (mean difference, -0.23; 95% CI, -0.37 to

179 weeks, participants underwent best-corrected visual acuity measurement, fundus examination, and spect

180 81 articles reviewed, 807 (42.9%) provided a visual acuity measurement.

181 llen format to improve ease of understanding visual acuity measurements.

182 d intravitreal corticosteroids and had final visual acuities of 20/40, 20/70, and hand movements.

183 disease, diabetes, or neurologic disorders; visual acuity of >/=20/25; refraction between -6 diopter

184 in the better eye) and blindness (presenting visual acuity of <3/60 in the better eye) by cause, age,

185 ere vision impairment (defined as presenting visual acuity of <6/18 but >/=3/60 in the better eye) an

186 ts (95.8%, 46 of 48 eyes) had a preoperative visual acuity of 20/200 or worse.

187 lture-positive filamentous fungal ulcers and visual acuity of 20/40 to 20/400 reexamined 6 days after

188 Participants had a baseline visual acuity of 20/400 or worse and were randomized to

189 s or older with, in each eye, best corrected visual acuity of 20/60 or worse, or visual field less th

190 34.2 (14.7) years, mean (SD) best-corrected visual acuity of all eyes was 47.8 (16.9) Early Treatmen

191 low MS (<6 dB) but very good best-corrected visual acuity of at least 72 Early Treatment Diabetic Re

192 to 15 years who underwent screening, 694 had visual acuity of less than 6/9 in both eyes, and 535 und

193 In these three patients, the last documented visual acuity on the Snellen eye chart before the inject

194 a full ophthalmologic examination, including visual acuity, optical coherence tomography B-scan, and

195 ery for 2 patients and persistent severe low visual acuity or blindness for 5 patients.

196 , bilateral uveitis (OR 3.51, P = .009), low visual acuity (OR 5.1, P = .001), high laser-flare (LF)

197 acuity as a predictor of final postoperative visual acuity outcome (r=-0.32; P = 0.09; 95% confidence

198 TZD usage had no effect on the ultimate visual acuity outcome.

199 Visual acuity outcomes did not differ between apex LD an

200 Visual acuity outcomes favored the E10030 1.5 mg combina

201 sician relationship and to positively impact visual acuity outcomes in ophthalmic diseases.

202 we found no association between TZD use and visual acuity outcomes or DME progression, and no consis

203 Visual acuity outcomes were determined for each early re

204 presenting clinical features, visual acuity outcomes, and antibiotic susceptibility pa

205 To investigate refractive and visual acuity outcomes, patient satisfaction, and specta

206 Visual acuity outcomes, postoperative complications, and

207 fectiveness of some treatments for improving visual acuity outcomes.

208 ere was a 3- to 5-letter improvement in mean visual acuity over the 3 months after the switching rule

209 ted standardized eye examinations, including visual acuity, perimetry, slit-lamp examination, intraoc

210 Best-corrected postoperative visual acuity, postoperative complications of the report

211 Decreased visual acuity preceded conversion by up to 2 months and

212 Visual acuity progressively declined from stage 1 throug

213 Presenting visual acuities ranged from 20/25 to hand motion.

214 ine, including microperimetry, low-luminance visual acuity, reading speed assessments, and patient-re

215 Similarly, visual acuity recovers or improves within 1 month of the

216 sive ophthalmological examination, including visual acuity, refraction, and ocular motility tests; an

217 n and LASIK surgery), and clinical measures (visual acuity, refractive error, and slitlamp and poster

218 Visual acuity remained unchanged following revision.

219 d authors to provide Snellen equivalents for visual acuity reported in non-Snellen formats.

220 gh December 14, 2016, one reviewer evaluated visual acuity reporting among all articles published in

221 Frequency of formats of visual acuity reporting and frequency of providing Snell

222 functional distance, intermediate, and near visual acuity, resulting in high levels of both spectacl

223 Ten-year rates of visual acuity retention were 8.7% (95% CI, 4.1%-15.6%) f

224 e measure was the change in the preoperative visual acuity score at postoperative month 1 and at the

225 r degeneration and a baseline best-corrected visual acuity score of 20/100 or less in the study eye w

226 Of the 3 symptomatic subjects, 2 had reduced visual acuity secondary to nonorganic visual loss and bi

227 One patient developed decreased visual acuity secondary to radiation retinopathy.

228 Visual acuity, size of RCH, and degree of exudation were

229 Visual acuity, size of RCH, and degree of exudation.

230 lysis of clinical ocular findings, including visual acuity, slit-lamp biomicroscopy, spectral-domain

231 uding medical history review, best-corrected visual acuity, slitlamp biomicroscopy, intraocular press

232 To analyze the long-term visual acuity, strabismus, and nystagmus outcomes in Gro

233 Visual acuity survival analyses indicate that the optima

234 Age at onset, visual acuity survival time, visual acuity decline rate,

235 To maximize visual acuity, the fovea should only contain photorecept

236 istance visual acuity and corrected distance visual acuity, the occurrence of suction loss during the

237 the oedema with a significant improvement in visual acuity to 20/20.

238 his network demonstrated the relationship of visual acuity to specific, programmed changes in OCT cha

239 uncorrected and spectacle corrected distance visual acuity (UCDVA/CDVA), automated kerato-refractomet

240 s including manifest refraction; uncorrected visual acuity (UCVA) and distance-corrected visual acuit

241 12 +/- 0.1 logMAR; mean uncorrected distance visual acuity (UDVA) also improved significantly from 0.

242 ity: AT Lisa, binocular uncorrected distance visual acuity (UDVA), -0.01 logMAR +/- 0.06; monocular d

243 +/- 0.08; binocular uncorrected intermediate visual acuity (UIVA) at 80 cm, -0.05 logMAR +/- 0.14; po

244 logMAR +/- 0.06; binocular uncorrected near visual acuity (UNVA) at 40 cm, 0.05 logMAR +/- 0.08; bin

245 AMD participants had better-eye visual acuity (VA) <20/32 and >20/100, while controls ha

246 ty-four study eyes from 305 adults with PDR, visual acuity (VA) 20/320 or better, and no history of P

247 To compare baseline characteristics, visual acuity (VA) and morphological outcomes between ey

248 Change in visual acuity (VA) and occurrence of intraoperative and

249 A 12-month phase 3b visual acuity (VA) assessor-masked, multicenter, randomi

250 edema (ME) is the leading cause of decreased visual acuity (VA) associated with retinal vein occlusio

251 nocular defocus curve showed peaks with best visual acuity (VA) at 0.00 D (-0.07 logMAR) and -2.00 D

252 on between use of thiazolidinediones (TZDs), visual acuity (VA) change, and diabetic eye disease inci

253 m FS and maximum GA area allowing sufficient visual acuity (VA) for daily tasks.

254 coherence tomography (SDOCT) correlates with visual acuity (VA) in eyes with uveitic cystoid macular

255 prospective observational studies reporting visual acuity (VA) in non-treated patients, 24 studies i

256 In the HSK group, the level of visual acuity (VA) in the affected eye had the greatest

257 tudies have demonstrated that the better the visual acuity (VA) is at the time of treatment initiatio

258 The primary outcome was mean change in visual acuity (VA) letter score (VALS) from the randomiz

259 Data including age, sex, visual acuity (VA) measured on Early Treatment Diabetic

260 otic susceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by

261 ith or without laser using an individualized visual acuity (VA) stabilization criteria in patients wi

262 Visual acuity (VA) was measured during their encounter o

263 Risk factors for final visual acuity (VA) were analyzed, and rate of strabismus

264 lar contrast sensitivity (CS) and better-eye visual acuity (VA) were evaluated, and 24-2 VFs were obt

265 come measures included surgical feasibility, visual acuity (VA), and complications.

266 al referral approach and assesses presenting visual acuity (VA), best-corrected VA, digital fundus im

267 ion of surgery, level of patient discomfort, visual acuity (VA), surgically induced refractive change

268 cluded a comprehensive clinical examination, visual acuity (VA), visual fields, electroretinography,

269 ary outcome measures included mean change in visual acuity (VA), vitreous haze (VH), and central macu

270 alities, lens and retinal abnormalities, and visual acuity (VA).

271 erplot smoothing curves were used to display visual acuity (VA).

272 y, full-field electroretinogram (ffERG), and visual acuity (VA).

273 tment is associated with less improvement in visual acuity (VA).

274 e tomography (SD OCT) and the correlation to visual acuity (VA).

275 of the minimum angle of resolution [logMAR] visual acuity [VA]) were evaluated in the 81 patients in

276 k developed is able to generate an estimated visual acuity value from OCT images in a population of p

277 Mesopic binocular uncorrected visual acuity values were similar to photopic values.

278 Comparison was made of visual acuity, visual field height, global RNFL thicknes

279 sures include IOP, glaucoma medical therapy, visual acuity, visual fields, and surgical complications

280 Clinical testing included visual acuity, visual fields, optical coherence tomograp

281 Visual acuity was 0.18 logarithm of the minimum angle of

282 Visual acuity was 0.4 and 0.07 after 5 years in the bett

283 Visual acuity was 20/20 OU, and color vision was normal

284 The preoperative mean visual acuity was 20/625 (range, hand motions to 20/20).

285 Initial visual acuity was associated with the prognosis.

286 Visual acuity was blind (VA >20/400) in 38.5% of eyes wi

287 Asymmetry in visual acuity was found in 31% of patients.

288 Presenting visual acuity was generally poor (20/50 to >20/200 in 27

289 Best-corrected visual acuity was improved in 13 eyes (81.25%), remained

290 Best-corrected visual acuity was measured using the Early Treatment Dia

291 Uniocular presenting distance visual acuity was measured using the logMAR chart.

292 r 8 days of topical corticosteroid treatment visual acuity was worsening with similar optical coheren

293 Only 1 outcome (visual acuity) was consistently reported in greater than

294 Mean preoperative and postoperative visual acuities were similar (20/60 vs. 20/80, respectiv

295 y individuals in the implant group with poor visual acuity were able to overcome their initial defici

296 mean IOP, mean glaucoma medication use, and visual acuity were compared.

297 10- and >/=15-letter gains in best-corrected visual acuity were observed in 34.5% (10/29) and 24.1% (

298 ed standards of utility for a given level of visual acuity were used to derive costs and quality-adju

299 Using habitual distance visual acuity (with correction if prescribed), participa

300 the implant group, individuals with initial visual acuity worse than 20/40 showed additional improve